Tanshinone IIA Downregulates HMGB1 and TLR4 Expression in a Spinal Nerve Ligation Model of Neuropathic Pain

Fifty-four Sprague-Dawley rats weighing 200~240 g were randomly divided into sham-operated group (sham group), vehicle-treated SNL group (model group), and Tan IIA-treated SNL group (Tan IIA group). Tan IIA was administered intraperitoneally to rats in the Tan IIA-treated group at a dose of 30 mg/kg...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Evidence-based complementary and alternative medicine 2014-01, Vol.2014 (2014), p.1-8
Hauptverfasser: Wu, Zhi-Wei, Leng, Yu-Fang, Chen, Yi-Rong, Ma, Yu-Qing
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 8
container_issue 2014
container_start_page 1
container_title Evidence-based complementary and alternative medicine
container_volume 2014
creator Wu, Zhi-Wei
Leng, Yu-Fang
Chen, Yi-Rong
Ma, Yu-Qing
description Fifty-four Sprague-Dawley rats weighing 200~240 g were randomly divided into sham-operated group (sham group), vehicle-treated SNL group (model group), and Tan IIA-treated SNL group (Tan IIA group). Tan IIA was administered intraperitoneally to rats in the Tan IIA-treated group at a dose of 30 mg/kg daily for 14 days after SNL surgery. Paw withdrawal mechanical thresholds (PWTs) and paw withdrawal thermal latencies (PWLs) were measured. High-mobility group box 1 (HMGB1) and Toll-like Receptor 4 (TLR4) mRNA and protein expression in the spinal cord were measured. Tumour necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-10 (IL-10) in the spinal cord were measured, too. Both the mechanical and heat pain thresholds were significantly decreased. After Tan IIA treatment, HMGB1, and TLR4 mRNA and protein levels, the expression of TNF-α and IF-1β was reduced significantly. In conclusion, Tanshinone IIA reversed SNL-induced thermal hyperalgesia and mechanical allodynia and downregulated HMGB1 and TLR4 levels and inhibited the HMGB1-TLR4 pathway. Tanshinone IIA inhibited TNF-α and IL-1β expression but not IF-10 expression in the spinal cords of SNL rats. These results indicate that Tanshinone IIA inhibited SNL-induced neuropathic pain via multiple effects, and targeting the HMGB1-TLR4 pathway could serve as the basis of new antinociceptive agents.
doi_str_mv 10.1155/2014/639563
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4120799</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A417106388</galeid><sourcerecordid>A417106388</sourcerecordid><originalsourceid>FETCH-LOGICAL-c561t-b0e3a1f89a5e7a1ae9b9755d3fa2ee62a3077a6a0ead67684aa2c7185d7df38a3</originalsourceid><addsrcrecordid>eNqNkc1vEzEQxVcIREvhxB1Z4oJAof5Yf-ylUiiljZQCgiBxsya7s4nLxl7s3Rb-exylhMKJk0een97MvFcUTxl9zZiUx5yy8liJSipxrzhkumSTkhtzf1_rrwfFo5SuKOWV1vphccAl41RqdVh8W4BPa-eDRzKbTcnbcOMjrsYOBkzk4vL8DSPgG7KYfyrJ2Y8-YkoueOI8AfK5dx468h7jNZK5W8GwbV2GBjsS2vw_xtDDsHY1-QjOPy4etNAlfHL7HhVf3p0tTi8m8w_ns9PpfFJLxYbJkqIA1poKJGpggNWy0lI2ogWOqDgIqjUooAiN0sqUALzWzMhGN60wII6Kk51uPy432NTohwid7aPbQPxpAzj7d8e7tV2Fa1tmV3RVZYEXtwIxfB8xDXbjUo1dBx7DmGx2XWhalXqLPv8HvQpjzK4ky6mihom84h9qBR1a59uQ59ZbUTstmWZUCWMy9WpH1TGkFLHdr8yo3UZtt1HbXdSZfnb3yj37O9sMvNwBOd4Gbtz_qWFGsIU7MDPacPELuLW5EQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2060813676</pqid></control><display><type>article</type><title>Tanshinone IIA Downregulates HMGB1 and TLR4 Expression in a Spinal Nerve Ligation Model of Neuropathic Pain</title><source>Wiley Online Library Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>PubMed Central Open Access</source><creator>Wu, Zhi-Wei ; Leng, Yu-Fang ; Chen, Yi-Rong ; Ma, Yu-Qing</creator><contributor>Sandner-Kiesling, Andreas ; Andreas Sandner-Kiesling</contributor><creatorcontrib>Wu, Zhi-Wei ; Leng, Yu-Fang ; Chen, Yi-Rong ; Ma, Yu-Qing ; Sandner-Kiesling, Andreas ; Andreas Sandner-Kiesling</creatorcontrib><description>Fifty-four Sprague-Dawley rats weighing 200~240 g were randomly divided into sham-operated group (sham group), vehicle-treated SNL group (model group), and Tan IIA-treated SNL group (Tan IIA group). Tan IIA was administered intraperitoneally to rats in the Tan IIA-treated group at a dose of 30 mg/kg daily for 14 days after SNL surgery. Paw withdrawal mechanical thresholds (PWTs) and paw withdrawal thermal latencies (PWLs) were measured. High-mobility group box 1 (HMGB1) and Toll-like Receptor 4 (TLR4) mRNA and protein expression in the spinal cord were measured. Tumour necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-10 (IL-10) in the spinal cord were measured, too. Both the mechanical and heat pain thresholds were significantly decreased. After Tan IIA treatment, HMGB1, and TLR4 mRNA and protein levels, the expression of TNF-α and IF-1β was reduced significantly. In conclusion, Tanshinone IIA reversed SNL-induced thermal hyperalgesia and mechanical allodynia and downregulated HMGB1 and TLR4 levels and inhibited the HMGB1-TLR4 pathway. Tanshinone IIA inhibited TNF-α and IL-1β expression but not IF-10 expression in the spinal cords of SNL rats. These results indicate that Tanshinone IIA inhibited SNL-induced neuropathic pain via multiple effects, and targeting the HMGB1-TLR4 pathway could serve as the basis of new antinociceptive agents.</description><identifier>ISSN: 1741-427X</identifier><identifier>EISSN: 1741-4288</identifier><identifier>DOI: 10.1155/2014/639563</identifier><identifier>PMID: 25120576</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Care and treatment ; Chinese medicine ; Chromatin ; Chronic pain ; Cytokines ; Gene expression ; Health aspects ; HMGB1 protein ; Hyperalgesia ; Interleukin 1 ; Interleukin 10 ; mRNA ; Neuralgia ; Neurosciences ; Pain ; Pain perception ; Physiological aspects ; Properties ; Quinone ; Rats ; Rodents ; Spinal cord ; Surgery ; Thresholds ; TLR4 protein ; Toll-like receptors ; Tumor necrosis factor-α ; Tumors</subject><ispartof>Evidence-based complementary and alternative medicine, 2014-01, Vol.2014 (2014), p.1-8</ispartof><rights>Copyright © 2014 Yu-Qing Ma et al.</rights><rights>COPYRIGHT 2014 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2014 Yu-Qing Ma et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2014 Yu-Qing Ma et al. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c561t-b0e3a1f89a5e7a1ae9b9755d3fa2ee62a3077a6a0ead67684aa2c7185d7df38a3</citedby><cites>FETCH-LOGICAL-c561t-b0e3a1f89a5e7a1ae9b9755d3fa2ee62a3077a6a0ead67684aa2c7185d7df38a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120799/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120799/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25120576$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Sandner-Kiesling, Andreas</contributor><contributor>Andreas Sandner-Kiesling</contributor><creatorcontrib>Wu, Zhi-Wei</creatorcontrib><creatorcontrib>Leng, Yu-Fang</creatorcontrib><creatorcontrib>Chen, Yi-Rong</creatorcontrib><creatorcontrib>Ma, Yu-Qing</creatorcontrib><title>Tanshinone IIA Downregulates HMGB1 and TLR4 Expression in a Spinal Nerve Ligation Model of Neuropathic Pain</title><title>Evidence-based complementary and alternative medicine</title><addtitle>Evid Based Complement Alternat Med</addtitle><description>Fifty-four Sprague-Dawley rats weighing 200~240 g were randomly divided into sham-operated group (sham group), vehicle-treated SNL group (model group), and Tan IIA-treated SNL group (Tan IIA group). Tan IIA was administered intraperitoneally to rats in the Tan IIA-treated group at a dose of 30 mg/kg daily for 14 days after SNL surgery. Paw withdrawal mechanical thresholds (PWTs) and paw withdrawal thermal latencies (PWLs) were measured. High-mobility group box 1 (HMGB1) and Toll-like Receptor 4 (TLR4) mRNA and protein expression in the spinal cord were measured. Tumour necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-10 (IL-10) in the spinal cord were measured, too. Both the mechanical and heat pain thresholds were significantly decreased. After Tan IIA treatment, HMGB1, and TLR4 mRNA and protein levels, the expression of TNF-α and IF-1β was reduced significantly. In conclusion, Tanshinone IIA reversed SNL-induced thermal hyperalgesia and mechanical allodynia and downregulated HMGB1 and TLR4 levels and inhibited the HMGB1-TLR4 pathway. Tanshinone IIA inhibited TNF-α and IL-1β expression but not IF-10 expression in the spinal cords of SNL rats. These results indicate that Tanshinone IIA inhibited SNL-induced neuropathic pain via multiple effects, and targeting the HMGB1-TLR4 pathway could serve as the basis of new antinociceptive agents.</description><subject>Care and treatment</subject><subject>Chinese medicine</subject><subject>Chromatin</subject><subject>Chronic pain</subject><subject>Cytokines</subject><subject>Gene expression</subject><subject>Health aspects</subject><subject>HMGB1 protein</subject><subject>Hyperalgesia</subject><subject>Interleukin 1</subject><subject>Interleukin 10</subject><subject>mRNA</subject><subject>Neuralgia</subject><subject>Neurosciences</subject><subject>Pain</subject><subject>Pain perception</subject><subject>Physiological aspects</subject><subject>Properties</subject><subject>Quinone</subject><subject>Rats</subject><subject>Rodents</subject><subject>Spinal cord</subject><subject>Surgery</subject><subject>Thresholds</subject><subject>TLR4 protein</subject><subject>Toll-like receptors</subject><subject>Tumor necrosis factor-α</subject><subject>Tumors</subject><issn>1741-427X</issn><issn>1741-4288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkc1vEzEQxVcIREvhxB1Z4oJAof5Yf-ylUiiljZQCgiBxsya7s4nLxl7s3Rb-exylhMKJk0een97MvFcUTxl9zZiUx5yy8liJSipxrzhkumSTkhtzf1_rrwfFo5SuKOWV1vphccAl41RqdVh8W4BPa-eDRzKbTcnbcOMjrsYOBkzk4vL8DSPgG7KYfyrJ2Y8-YkoueOI8AfK5dx468h7jNZK5W8GwbV2GBjsS2vw_xtDDsHY1-QjOPy4etNAlfHL7HhVf3p0tTi8m8w_ns9PpfFJLxYbJkqIA1poKJGpggNWy0lI2ogWOqDgIqjUooAiN0sqUALzWzMhGN60wII6Kk51uPy432NTohwid7aPbQPxpAzj7d8e7tV2Fa1tmV3RVZYEXtwIxfB8xDXbjUo1dBx7DmGx2XWhalXqLPv8HvQpjzK4ky6mihom84h9qBR1a59uQ59ZbUTstmWZUCWMy9WpH1TGkFLHdr8yo3UZtt1HbXdSZfnb3yj37O9sMvNwBOd4Gbtz_qWFGsIU7MDPacPELuLW5EQ</recordid><startdate>20140101</startdate><enddate>20140101</enddate><creator>Wu, Zhi-Wei</creator><creator>Leng, Yu-Fang</creator><creator>Chen, Yi-Rong</creator><creator>Ma, Yu-Qing</creator><general>Hindawi Publishing Corporation</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M2M</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20140101</creationdate><title>Tanshinone IIA Downregulates HMGB1 and TLR4 Expression in a Spinal Nerve Ligation Model of Neuropathic Pain</title><author>Wu, Zhi-Wei ; Leng, Yu-Fang ; Chen, Yi-Rong ; Ma, Yu-Qing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c561t-b0e3a1f89a5e7a1ae9b9755d3fa2ee62a3077a6a0ead67684aa2c7185d7df38a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Care and treatment</topic><topic>Chinese medicine</topic><topic>Chromatin</topic><topic>Chronic pain</topic><topic>Cytokines</topic><topic>Gene expression</topic><topic>Health aspects</topic><topic>HMGB1 protein</topic><topic>Hyperalgesia</topic><topic>Interleukin 1</topic><topic>Interleukin 10</topic><topic>mRNA</topic><topic>Neuralgia</topic><topic>Neurosciences</topic><topic>Pain</topic><topic>Pain perception</topic><topic>Physiological aspects</topic><topic>Properties</topic><topic>Quinone</topic><topic>Rats</topic><topic>Rodents</topic><topic>Spinal cord</topic><topic>Surgery</topic><topic>Thresholds</topic><topic>TLR4 protein</topic><topic>Toll-like receptors</topic><topic>Tumor necrosis factor-α</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wu, Zhi-Wei</creatorcontrib><creatorcontrib>Leng, Yu-Fang</creatorcontrib><creatorcontrib>Chen, Yi-Rong</creatorcontrib><creatorcontrib>Ma, Yu-Qing</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Evidence-based complementary and alternative medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wu, Zhi-Wei</au><au>Leng, Yu-Fang</au><au>Chen, Yi-Rong</au><au>Ma, Yu-Qing</au><au>Sandner-Kiesling, Andreas</au><au>Andreas Sandner-Kiesling</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tanshinone IIA Downregulates HMGB1 and TLR4 Expression in a Spinal Nerve Ligation Model of Neuropathic Pain</atitle><jtitle>Evidence-based complementary and alternative medicine</jtitle><addtitle>Evid Based Complement Alternat Med</addtitle><date>2014-01-01</date><risdate>2014</risdate><volume>2014</volume><issue>2014</issue><spage>1</spage><epage>8</epage><pages>1-8</pages><issn>1741-427X</issn><eissn>1741-4288</eissn><abstract>Fifty-four Sprague-Dawley rats weighing 200~240 g were randomly divided into sham-operated group (sham group), vehicle-treated SNL group (model group), and Tan IIA-treated SNL group (Tan IIA group). Tan IIA was administered intraperitoneally to rats in the Tan IIA-treated group at a dose of 30 mg/kg daily for 14 days after SNL surgery. Paw withdrawal mechanical thresholds (PWTs) and paw withdrawal thermal latencies (PWLs) were measured. High-mobility group box 1 (HMGB1) and Toll-like Receptor 4 (TLR4) mRNA and protein expression in the spinal cord were measured. Tumour necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-10 (IL-10) in the spinal cord were measured, too. Both the mechanical and heat pain thresholds were significantly decreased. After Tan IIA treatment, HMGB1, and TLR4 mRNA and protein levels, the expression of TNF-α and IF-1β was reduced significantly. In conclusion, Tanshinone IIA reversed SNL-induced thermal hyperalgesia and mechanical allodynia and downregulated HMGB1 and TLR4 levels and inhibited the HMGB1-TLR4 pathway. Tanshinone IIA inhibited TNF-α and IL-1β expression but not IF-10 expression in the spinal cords of SNL rats. These results indicate that Tanshinone IIA inhibited SNL-induced neuropathic pain via multiple effects, and targeting the HMGB1-TLR4 pathway could serve as the basis of new antinociceptive agents.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>25120576</pmid><doi>10.1155/2014/639563</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1741-427X
ispartof Evidence-based complementary and alternative medicine, 2014-01, Vol.2014 (2014), p.1-8
issn 1741-427X
1741-4288
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4120799
source Wiley Online Library Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection; PubMed Central Open Access
subjects Care and treatment
Chinese medicine
Chromatin
Chronic pain
Cytokines
Gene expression
Health aspects
HMGB1 protein
Hyperalgesia
Interleukin 1
Interleukin 10
mRNA
Neuralgia
Neurosciences
Pain
Pain perception
Physiological aspects
Properties
Quinone
Rats
Rodents
Spinal cord
Surgery
Thresholds
TLR4 protein
Toll-like receptors
Tumor necrosis factor-α
Tumors
title Tanshinone IIA Downregulates HMGB1 and TLR4 Expression in a Spinal Nerve Ligation Model of Neuropathic Pain
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T04%3A11%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tanshinone%20IIA%20Downregulates%20HMGB1%20and%20TLR4%20Expression%20in%20a%20Spinal%20Nerve%20Ligation%20Model%20of%20Neuropathic%20Pain&rft.jtitle=Evidence-based%20complementary%20and%20alternative%20medicine&rft.au=Wu,%20Zhi-Wei&rft.date=2014-01-01&rft.volume=2014&rft.issue=2014&rft.spage=1&rft.epage=8&rft.pages=1-8&rft.issn=1741-427X&rft.eissn=1741-4288&rft_id=info:doi/10.1155/2014/639563&rft_dat=%3Cgale_pubme%3EA417106388%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2060813676&rft_id=info:pmid/25120576&rft_galeid=A417106388&rfr_iscdi=true